IFNG and cancer: The decrease in type 1 cytokines (e.g., IL-2, IL-12p70, and IFN-γ) may lead to decreased cell-mediated immunity, which together with a decrease in pro-inflammatory cytokines (e.g., IL-8) may result in increased risk of infection and cancer [41,42].